FEG
ABBV icon

Financial Enhancement Group’s AbbVie ABBV Stock Holding History

Financial Enhancement Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$246K Sell
905
-6
-0.7% -$1.54K 0.03% 128
2026
Q2 		$229K Buy
+911
New +$196K 0.03% 132
2022
Q4 		– Sell
-13,172
Closed -$1.77M – 115
2022
Q3 		$1.77M Buy
+13,172
New +$1.89M 0.41% 48
2018
Q3 		– Sell
-187
Closed -$17K – 245
2018
Q2 		$17K Hold
187
– – 0.01% 153
2018
Q1 		$18K Buy
+187
New +$20.5K 0.01% 156

Other funds holding ABBV

HCM
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Financial Enhancement Group's ABBV Position: Q3 2026 in Review

Financial Enhancement Group reduced its AbbVie (ABBV) stake by 0.66% in Q3 2026, selling an estimated $1.54K and leaving 905 shares worth $246K. The position accounts for 0.03% of the portfolio, ranked #128.

Financial Enhancement Group first reported a position in ABBV in Q1 2018 and has held it in 5 quarters since. The position peaked at $1.77M in Q3 2022. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Financial Enhancement Group held 905 shares of AbbVie worth $246K as of Q3 2026.
  • Financial Enhancement Group sold 6 AbbVie shares in Q3 2026, an estimated $1.54K.
  • AbbVie made up 0.03% of Financial Enhancement Group's portfolio in Q3 2026, its #128 holding.
  • Financial Enhancement Group first reported a position in AbbVie in Q1 2018 and has held it in 5 quarters since.
  • Financial Enhancement Group's AbbVie position peaked at $1.77M in Q3 2022.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Financial Enhancement Group's 13F filing for Q3 2026, filed 8 Oct 2026.